These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

825 related articles for article (PubMed ID: 26205347)

  • 1. Inhibition of class I histone deacetylases by romidepsin potently induces Epstein-Barr virus lytic cycle and mediates enhanced cell death with ganciclovir.
    Hui KF; Cheung AK; Choi CK; Yeung PL; Middeldorp JM; Lung ML; Tsao SW; Chiang AK
    Int J Cancer; 2016 Jan; 138(1):125-36. PubMed ID: 26205347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Novel Small Organic Compounds with Diverse Structures for the Induction of Epstein-Barr Virus (EBV) Lytic Cycle in EBV-Positive Epithelial Malignancies.
    Choi CK; Ho DN; Hui KF; Kao RY; Chiang AK
    PLoS One; 2015; 10(12):e0145994. PubMed ID: 26717578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Epstein-Barr virus reactivation in nasopharyngeal carcinoma cells by dietary sulforaphane.
    Wu CC; Chuang HY; Lin CY; Chen YJ; Tsai WH; Fang CY; Huang SY; Chuang FY; Lin SF; Chang Y; Chen JY
    Mol Carcinog; 2013 Dec; 52(12):946-58. PubMed ID: 22641235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy induces lytic EBV replication and confers ganciclovir susceptibility to EBV-positive epithelial cell tumors.
    Feng WH; Israel B; Raab-Traub N; Busson P; Kenney SC
    Cancer Res; 2002 Mar; 62(6):1920-6. PubMed ID: 11912175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bortezomib and SAHA synergistically induce ROS-driven caspase-dependent apoptosis of nasopharyngeal carcinoma and block replication of Epstein-Barr virus.
    Hui KF; Lam BH; Ho DN; Tsao SW; Chiang AK
    Mol Cancer Ther; 2013 May; 12(5):747-58. PubMed ID: 23475956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted therapy for Epstein-Barr virus-associated gastric carcinoma using low-dose gemcitabine-induced lytic activation.
    Lee HG; Kim H; Kim EJ; Park PG; Dong SM; Choi TH; Kim H; Chong CR; Liu JO; Chen J; Ambinder RF; Hayward SD; Park JH; Lee JM
    Oncotarget; 2015 Oct; 6(31):31018-29. PubMed ID: 26427042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of lytic cycle of Epstein-Barr virus by suberoylanilide hydroxamic acid leads to apoptosis and tumor growth suppression of nasopharyngeal carcinoma.
    Hui KF; Ho DN; Tsang CM; Middeldorp JM; Tsao GS; Chiang AK
    Int J Cancer; 2012 Oct; 131(8):1930-40. PubMed ID: 22261816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suberoylanilide hydroxamic acid induces viral lytic cycle in Epstein-Barr virus-positive epithelial malignancies and mediates enhanced cell death.
    Hui KF; Chiang AK
    Int J Cancer; 2010 May; 126(10):2479-89. PubMed ID: 19816947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of proteasome and class I HDAC inhibitors induces apoptosis of NPC cells through an HDAC6-independent ER stress-induced mechanism.
    Hui KF; Chiang AK
    Int J Cancer; 2014 Dec; 135(12):2950-61. PubMed ID: 24771510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valpromide Inhibits Lytic Cycle Reactivation of Epstein-Barr Virus.
    Gorres KL; Daigle D; Mohanram S; McInerney GE; Lyons DE; Miller G
    mBio; 2016 Mar; 7(2):e00113. PubMed ID: 26933051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone Modifications as Molecular Targets in Nasopharyngeal Cancer.
    Shyamasundar S; Dheen ST; Bay BH
    Curr Med Chem; 2016; 23(2):186-97. PubMed ID: 26549431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase inhibitor romidepsin induces efficient tumor cell lysis via selective down-regulation of LMP1 and c-myc expression in EBV-positive diffuse large B-cell lymphoma.
    Shin DY; Kim A; Kang HJ; Park S; Kim DW; Lee SS
    Cancer Lett; 2015 Aug; 364(2):89-97. PubMed ID: 25790907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of lytic Epstein-Barr virus (EBV) infection by radiation and sodium butyrate in vitro and in vivo: a potential method for treating EBV-positive malignancies.
    Westphal EM; Blackstock W; Feng W; Israel B; Kenney SC
    Cancer Res; 2000 Oct; 60(20):5781-8. PubMed ID: 11059774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF-kappaB inhibitors induce lytic cytotoxicity in Epstein-Barr virus-positive nasopharyngeal carcinoma cells.
    Liu SF; Wang H; Lin XC; Xiang H; Deng XY; Li W; Tang M; Cao Y
    Cell Biol Int; 2008 Aug; 32(8):1006-13. PubMed ID: 18579417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle.
    Gradoville L; Kwa D; El-Guindy A; Miller G
    J Virol; 2002 Jun; 76(11):5612-26. PubMed ID: 11991990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (-)-Epigallocatechin-3-gallate inhibition of Epstein-Barr virus spontaneous lytic infection involves ERK1/2 and PI3-K/Akt signaling in EBV-positive cells.
    Liu S; Li H; Chen L; Yang L; Li L; Tao Y; Li W; Li Z; Liu H; Tang M; Bode AM; Dong Z; Cao Y
    Carcinogenesis; 2013 Mar; 34(3):627-37. PubMed ID: 23180656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sildenafil prevents HDACi-induced Epstein-Barr virus reactivation through the PKG pathway in NK/T cell lymphoma; potential implications for HDACi-mediated fatal complications.
    Kim JH; Kim WS; Park C
    Antiviral Res; 2021 May; 189():105063. PubMed ID: 33741394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a new class of small molecules that efficiently reactivate latent Epstein-Barr Virus.
    Tikhmyanova N; Schultz DC; Lee T; Salvino JM; Lieberman PM
    ACS Chem Biol; 2014 Mar; 9(3):785-95. PubMed ID: 24028149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.
    Ye J; Gradoville L; Daigle D; Miller G
    J Virol; 2007 Sep; 81(17):9279-91. PubMed ID: 17596302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. hTERT inhibition triggers Epstein-Barr virus lytic cycle and apoptosis in immortalized and transformed B cells: a basis for new therapies.
    Giunco S; Dolcetti R; Keppel S; Celeghin A; Indraccolo S; Dal Col J; Mastorci K; De Rossi A
    Clin Cancer Res; 2013 Apr; 19(8):2036-47. PubMed ID: 23444223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.